Corrigendum to 'Pharmacodynamic analysis of intravenous bolus remimazolam for loss of consciousness in patients undergoing general anaesthesia: a randomised, prospective, double-blind study' (Br J Anaesth 2022; 129: 49-57).

Chae, Dongwoo; Kim, Hyun-Chang; Song, Young; Choi, Young Seo; Han, Dong Woo

Chae, Dongwoo; Kim, Hyun-Chang; Song, Young; Choi, Young Seo; Han, Dong Woo.

Afiliación

Chae D; Department of Pharmacology, Yonsei University College of Medicine, Seoul, South Korea.
Kim HC; Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
Song Y; Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
Choi YS; Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
Han DW; Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, South Korea. Electronic address: hanesth@yuhs.ac.

Br J Anaesth ; 129(5): 831, 2022 Nov.

Article en En | MEDLINE | ID: mdl-36075773

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Br J Anaesth Año: 2022 Tipo del documento: Article País de afiliación: Corea del Sur

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google